EE541 Health Equity Improvements Driven By Faricimab for the Treatment of Diabetic Macular Edema in an Aggregate Distributional Cost-Effectiveness Analysis from an English NHS Perspective

Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.2519
https://www.valueinhealthjournal.com/article/S1098-3015(23)02709-2/fulltext
Section Title :
Section Order : 10307
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02709-2&doi=10.1016/j.jval.2023.03.2519
HEOR Topics :
Tags :
Regions :